BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hope S, Hoseth E, Dieset I, Mørch RH, Aas M, Aukrust P, Djurovic S, Melle I, Ueland T, Agartz I, Ueland T, Westlye LT, Andreassen OA. Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls. Schizophr Res 2015;165:188-94. [PMID: 25956633 DOI: 10.1016/j.schres.2015.04.004] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 8.9] [Reference Citation Analysis]
Number Citing Articles
1 Misiak B, Stańczykiewicz B, Kotowicz K, Rybakowski JK, Samochowiec J, Frydecka D. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review. Schizophr Res 2018;192:16-29. [PMID: 28416092 DOI: 10.1016/j.schres.2017.04.015] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 15.8] [Reference Citation Analysis]
2 Debnath M, Berk M. Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia. Mol Neurobiol 2017;54:8170-8. [PMID: 27900676 DOI: 10.1007/s12035-016-0309-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
3 McPhee GM, Downey LA, Stough C. Neurotrophins as a reliable biomarker for brain function, structure and cognition: A systematic review and meta-analysis. Neurobiol Learn Mem 2020;175:107298. [PMID: 32822863 DOI: 10.1016/j.nlm.2020.107298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Stamatovich SN, Lopez-gamundi P, Suchting R, Colpo GD, Walss-bass C, Lane SD, Schmitz JM, Wardle MC. Plasma pro- and anti-inflammatory cytokines may relate to cocaine use, cognitive functioning, and depressive symptoms in cocaine use disorder. The American Journal of Drug and Alcohol Abuse 2021;47:52-64. [DOI: 10.1080/00952990.2020.1828439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shonibare DO, Patel R, Islam AH, Metcalfe AW, Fiksenbaum L, Kennedy JL, Freeman N, Macintosh BJ, Goldstein BI. Preliminary study of structural magnetic resonance imaging phenotypes related to genetic variation in Interleukin-1β rs16944 in adolescents with Bipolar Disorder. Journal of Psychiatric Research 2020;122:33-41. [DOI: 10.1016/j.jpsychires.2019.12.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Fries GR, Walss-bass C, Bauer ME, Teixeira AL. Revisiting inflammation in bipolar disorder. Pharmacology Biochemistry and Behavior 2019;177:12-9. [DOI: 10.1016/j.pbb.2018.12.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 14.3] [Reference Citation Analysis]
7 Pardo CA, Farmer CA, Thurm A, Shebl FM, Ilieva J, Kalra S, Swedo S. Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study. Mol Autism 2017;8:1. [PMID: 28070266 DOI: 10.1186/s13229-016-0115-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
8 Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA. White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder. Aust N Z J Psychiatry 2017;51:355-65. [PMID: 27126391 DOI: 10.1177/0004867416644508] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
9 Al-Hakeim HK, Almulla AF, Maes M. The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study. Neurotox Res 2020;37:753-71. [PMID: 31916129 DOI: 10.1007/s12640-019-00112-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
10 Momtazmanesh S, Zare-Shahabadi A, Rezaei N. Cytokine Alterations in Schizophrenia: An Updated Review. Front Psychiatry 2019;10:892. [PMID: 31908647 DOI: 10.3389/fpsyt.2019.00892] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
11 Challa F, Seifu D, Sileshi M, Getahun T, Geto Z, Kassa D, Alemayehu M, Mesfin M, Fekadu A, Woldeamanuel Y. Serum level of high sensitive C-reactive protein and IL - 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study. BMC Psychiatry 2021;21:428. [PMID: 34465310 DOI: 10.1186/s12888-021-03443-4] [Reference Citation Analysis]
12 Engh JA, Ueland T, Agartz I, Andreou D, Aukrust P, Boye B, Bøen E, Drange OK, Elvsåshagen T, Hope S, Høegh MC, Joa I, Johnsen E, Kroken RA, Lagerberg TV, Lekva T, Malt UF, Melle I, Morken G, Nærland T, Steen VM, Wedervang-Resell K, Weibell MA, Westlye LT, Djurovic S, Steen NE, Andreassen OA. Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study. Schizophr Bull 2021:sbab106. [PMID: 34499169 DOI: 10.1093/schbul/sbab106] [Reference Citation Analysis]
13 Rosenblat JD, Mcintyre RS. Bipolar Disorder and Inflammation. Psychiatric Clinics of North America 2016;39:125-37. [DOI: 10.1016/j.psc.2015.09.006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 12.0] [Reference Citation Analysis]
14 Kessing LV, Miskowiak K. Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?-A Perspective Paper. Front Psychiatry 2018;9:490. [PMID: 30349492 DOI: 10.3389/fpsyt.2018.00490] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
15 Barichello T, Giridharan VV, Bhatti G, Sayana P, Doifode T, Macedo D, Quevedo J. Inflammation as a Mechanism of Bipolar Disorder Neuroprogression. Curr Top Behav Neurosci 2021;48:215-37. [PMID: 33040314 DOI: 10.1007/7854_2020_173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Melbourne JK, Rosen C, Feiner B, Sharma RP. C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis. Schizophr Res 2018;197:321-7. [PMID: 29449061 DOI: 10.1016/j.schres.2018.01.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
17 Orsolini L, Sarchione F, Vellante F, Fornaro M, Matarazzo I, Martinotti G, Valchera A, Di Nicola M, Carano A, Di Giannantonio M, Perna G, Olivieri L, De Berardis D. Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review. Curr Neuropharmacol 2018;16:583-606. [PMID: 29357805 DOI: 10.2174/1570159X16666180119144538] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
18 Ribeiro-santos R, de Campos-carli SM, Ferretjans R, Teixeira-carvalho A, Martins-filho OA, Teixeira AL, Salgado JV. The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment. Nordic Journal of Psychiatry 2020;74:187-93. [DOI: 10.1080/08039488.2019.1688389] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
19 Zheng W, Zhu X, Zhang Q, Cheng G, Cai D, He J, Ng CH, Ungvari GS, Peng X, Ning Y, Xiang Y. Adjunctive minocycline for major mental disorders: A systematic review. J Psychopharmacol 2019;33:1215-26. [DOI: 10.1177/0269881119858286] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
20 Sayana P, Colpo GD, Simões LR, Giridharan VV, Teixeira AL, Quevedo J, Barichello T. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. J Psychiatr Res 2017;92:160-82. [PMID: 28458141 DOI: 10.1016/j.jpsychires.2017.03.018] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 15.0] [Reference Citation Analysis]
21 Rodrigues-Amorim D, Rivera-Baltanás T, Spuch C, Caruncho HJ, González-Fernandez Á, Olivares JM, Agís-Balboa RC. Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship. Schizophr Res 2018;197:19-33. [PMID: 29239785 DOI: 10.1016/j.schres.2017.11.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
22 Köhler-Forsberg O, Sylvia LG, Bowden CL, Calabrese JR, Thase ME, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA. Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials. Acta Neuropsychiatr 2019;31:230-4. [PMID: 31169098 DOI: 10.1017/neu.2019.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Gao J, Wei Q, Pan R, Yi W, Xu Z, Duan J, Tang C, He Y, Liu X, Song S, Su H. Elevated environmental PM2.5 increases risk of schizophrenia relapse: Mediation of inflammatory cytokines. Science of The Total Environment 2021;753:142008. [DOI: 10.1016/j.scitotenv.2020.142008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
24 Sanchez-autet M, Arranz B, Safont G, Sierra P, Garcia-blanco A, de la Fuente L, Garriga M, García-portilla M. Gender differences in C-reactive protein and homocysteine modulation of cognitive performance and real-world functioning in bipolar disorder. Journal of Affective Disorders 2018;229:95-104. [DOI: 10.1016/j.jad.2017.12.038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
25 Ramakrishna C, Mendonca S, Ruegger PM, Kim JH, Borneman J, Cantin EM. Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis. PLoS One 2020;15:e0237189. [PMID: 32760124 DOI: 10.1371/journal.pone.0237189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Solmi M, Suresh Sharma M, Osimo EF, Fornaro M, Bortolato B, Croatto G, Miola A, Vieta E, Pariante CM, Smith L, Fusar-Poli P, Shin JI, Berk M, Carvalho AF. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability. Brain Behav Immun 2021:S0889-1591(21)00278-6. [PMID: 34332041 DOI: 10.1016/j.bbi.2021.07.014] [Reference Citation Analysis]
27 Ntouros E, Karanikas E, Floros G, Andreou C, Tsoura A, Garyfallos G, Bozikas VP. Social cognition in the course of psychosis and its correlation with biomarkers in a male cohort. Cogn Neuropsychiatry 2018;23:103-15. [PMID: 29447074 DOI: 10.1080/13546805.2018.1440201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Besga A, Chyzhyk D, Gonzalez-Ortega I, Echeveste J, Graña-Lecuona M, Graña M, Gonzalez-Pinto A. White Matter Tract Integrity in Alzheimer's Disease vs. Late Onset Bipolar Disorder and Its Correlation with Systemic Inflammation and Oxidative Stress Biomarkers. Front Aging Neurosci 2017;9:179. [PMID: 28670271 DOI: 10.3389/fnagi.2017.00179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Smucny J, Dienel SJ, Lewis DA, Carter CS. Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia. Neuropsychopharmacology 2021. [PMID: 34285373 DOI: 10.1038/s41386-021-01089-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
30 Boozalis T, Teixeira AL, Cho RY, Okusaga O. C-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia. Front Public Health 2017;5:360. [PMID: 29404313 DOI: 10.3389/fpubh.2017.00360] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
31 Werner MCF, Wirgenes KV, Shadrin A, Lunding SH, Rødevand L, Hjell G, Ormerod MBEG, Haram M, Agartz I, Djurovic S, Melle I, Aukrust P, Ueland T, Andreassen OA, Steen NE. Immune marker levels in severe mental disorders: associations with polygenic risk scores of related mental phenotypes and psoriasis. Transl Psychiatry 2022;12. [DOI: 10.1038/s41398-022-01811-6] [Reference Citation Analysis]
32 Chang CH, Lane HY, Liu CY, Cheng PC, Chen SJ, Lin CH. C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia. Neuropsychiatr Dis Treat 2019;15:2621-7. [PMID: 31571879 DOI: 10.2147/NDT.S223278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Poletti S, Vai B, Mazza MG, Zanardi R, Lorenzi C, Calesella F, Cazzetta S, Branchi I, Colombo C, Furlan R, Benedetti F. A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021;105:110136. [DOI: 10.1016/j.pnpbp.2020.110136] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
34 González-Blanco L, García-Portilla MP, García-Álvarez L, de la Fuente-Tomás L, Iglesias García C, Sáiz PA, Rodríguez-González S, Coto-Montes A, Bobes J. Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia? Rev Psiquiatr Salud Ment (Engl Ed) 2019;12:9-16. [PMID: 29724678 DOI: 10.1016/j.rpsm.2018.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Nerhus M, Berg AO, Kvitland LR, Dieset I, Hope S, Dahl SR, Weibell MA, Romm KL, Faerden A, Andreassen OA, Melle I. Low vitamin D is associated with negative and depressive symptoms in psychotic disorders. Schizophr Res 2016;178:44-9. [PMID: 27595553 DOI: 10.1016/j.schres.2016.08.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
36 Soczynska JK, Kennedy SH, Alsuwaidan M, Mansur RB, Li M, McAndrews MP, Brietzke E, Woldeyohannes HO, Taylor VH, McIntyre RS. A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression. Bipolar Disord 2017;19:198-213. [PMID: 28599348 DOI: 10.1111/bdi.12496] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 7.8] [Reference Citation Analysis]
37 Zhu J, Hu W, Zhou Y, Qiao J, Chang X, Tong Z. Serum high-sensitivity C-reactive protein levels are positively associated with cognitive impairments in patients with first-episode schizophrenia. Comprehensive Psychiatry 2019;94:152118. [DOI: 10.1016/j.comppsych.2019.152118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Sağlam Aykut D, Civil Arslan F, Özkorumak Karagüzel E, Aral G, Karakullukçu S. The relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and cognitive functions in bipolar disorder. Nord J Psychiatry 2018;72:119-23. [PMID: 29108448 DOI: 10.1080/08039488.2017.1397192] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
39 Poletti S, Mazza MG, Calesella F, Vai B, Lorenzi C, Manfredi E, Colombo C, Zanardi R, Benedetti F. Circulating inflammatory markers impact cognitive functions in bipolar depression. J Psychiatr Res 2021;140:110-6. [PMID: 34107379 DOI: 10.1016/j.jpsychires.2021.05.071] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Porcu M, Machado RCBR, Urbano M, Verri WA Jr, Rossaneis AC, Vargas HO, Nunes SOV. Depressed female smokers have higher levels of soluble tumor necrosis factor receptor 1. Addict Behav Rep 2018;7:90-5. [PMID: 29892702 DOI: 10.1016/j.abrep.2018.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Hua MH, Chen MH, Hsu JW, Huang KL, Tsai SJ, Li CT, Bai YM. Proinflammatory Cytokine Dysregulation and Cognitive Dysfunction Among Patients with Remitted Bipolar I and II Disorders. J Affect Disord 2021;281:738-43. [PMID: 33229027 DOI: 10.1016/j.jad.2020.11.079] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Rosenblat JD, Brietzke E, Mansur RB, Maruschak NA, Lee Y, McIntyre RS. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications. J Affect Disord 2015;188:149-59. [PMID: 26363613 DOI: 10.1016/j.jad.2015.08.058] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
43 Mørch RH, Dieset I, Færden A, Reponen EJ, Hope S, Hoseth EZ, Gardsjord ES, Aas M, Iversen T, Joa I, Morken G, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA. Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors. Psychol Med 2019;49:1749-57. [PMID: 30688187 DOI: 10.1017/S0033291718004142] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
44 Besga A, Gonzalez I, Echeburua E, Savio A, Ayerdi B, Chyzhyk D, Madrigal JL, Leza JC, Graña M, Gonzalez-Pinto AM. Discrimination between Alzheimer's Disease and Late Onset Bipolar Disorder Using Multivariate Analysis. Front Aging Neurosci 2015;7:231. [PMID: 26696883 DOI: 10.3389/fnagi.2015.00231] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
45 Postolache TT, Medoff DR, Brown CH, Fang LJ, Upadhyaya SK, Lowry CA, Miller M, Kreyenbuhl JA. Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in US Veterans with schizophrenia and bipolar disorder. Pteridines 2021;32:48-69. [PMID: 34887622 DOI: 10.1515/pteridines-2020-0028] [Reference Citation Analysis]
46 Morozova A, Zorkina Y, Abramova O, Pavlova O, Pavlov K, Soloveva K, Volkova M, Alekseeva P, Andryshchenko A, Kostyuk G, Gurina O, Chekhonin V. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders. Int J Mol Sci 2022;23:1217. [PMID: 35163141 DOI: 10.3390/ijms23031217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
47 O'Rourke L, Murphy KC. Recent developments in understanding the relationship between 22q11.2 deletion syndrome and psychosis. Curr Opin Psychiatry 2019;32:67-72. [PMID: 30394904 DOI: 10.1097/YCO.0000000000000466] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
48 Chumakov E, Dorofeikova M, Tsyrenova K, Petrova N. A Cross-Sectional Study on Associations Between BDNF, CRP, IL-6 and Clinical Symptoms, Cognitive and Personal Performance in Patients With Paranoid Schizophrenia. Front Psychiatry 2022;13:943869. [PMID: 35873262 DOI: 10.3389/fpsyt.2022.943869] [Reference Citation Analysis]
49 Scaini G, Valvassori SS, Diaz AP, Lima CN, Benevenuto D, Fries GR, Quevedo J. Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings. Braz J Psychiatry 2020;42:536-51. [PMID: 32267339 DOI: 10.1590/1516-4446-2019-0732] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
50 Bioque M, González-Rodríguez A, Garcia-Rizo C, Cobo J, Monreal JA, Usall J, Soria V, Labad J; PNECAT Group. Targeting the microbiome-gut-brain axis for improving cognition in schizophrenia and major mood disorders: A narrative review. Prog Neuropsychopharmacol Biol Psychiatry 2021;105:110130. [PMID: 33045322 DOI: 10.1016/j.pnpbp.2020.110130] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
51 Reponen EJ, Dieset I, Tesli M, Mørch RH, Aas M, Vedal TSJ, Haug E, Drange OK, Steen NE, Hope S, Szabo A, Gohar SM, Wedervang-Resell K, Djurovic S, Melle I, Aukrust P, Andreassen OA, Ueland T. Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders. Front Psychiatry 2020;11:672. [PMID: 32754070 DOI: 10.3389/fpsyt.2020.00672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Mørch RH, Dieset I, Færden A, Hope S, Aas M, Nerhus M, Gardsjord ES, Joa I, Morken G, Agartz I, Aukrust P, Djurovic S, Melle I, Ueland T, Andreassen OA. Inflammatory evidence for the psychosis continuum model. Psychoneuroendocrinology 2016;67:189-97. [DOI: 10.1016/j.psyneuen.2016.02.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
53 Besga A, Chyzhyk D, Graña M, Gonzalez-Pinto A. An Imaging and Blood Biomarkers Open Dataset on Alzheimer's Disease vs. Late Onset Bipolar Disorder. Front Aging Neurosci 2020;12:583212. [PMID: 33192477 DOI: 10.3389/fnagi.2020.583212] [Reference Citation Analysis]
54 Mørch RH, Dieset I, Faerden A, Hope S, Aas M, Nerhus M, Gardsjord ES, Haram M, Falk RS, Joa I, Morken G, Agartz I, Aukrust P, Djurovic S, Melle I, Ueland T, Andreassen OA. Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study. Acta Psychiatr Scand 2017;136:400-8. [PMID: 28815548 DOI: 10.1111/acps.12783] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
55 Fond G, Berna F, Andrianarisoa M, Godin O, Leboyer M, Brunel L, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Denizot H, Dubertret C, Dubreucq J, Faget C, Gabayet F, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Richieri R, Rey R, Schandrin A, Urbach M, Vidailhet P, Boyer L, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort. Eur Arch Psychiatry Clin Neurosci 2017;267:465-72. [PMID: 28238173 DOI: 10.1007/s00406-017-0771-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
56 Miller BJ, Herzig KH, Jokelainen J, Karhu T, Keinänen-Kiukaanniemi S, Järvelin MR, Veijola J, Viinamäki H, Päivikki Tanskanen, Jääskeläinen E, Isohanni M, Timonen M. Inflammation, hippocampal volume, and cognition in schizophrenia: results from the Northern Finland Birth Cohort 1966. Eur Arch Psychiatry Clin Neurosci 2021;271:609-22. [PMID: 32382794 DOI: 10.1007/s00406-020-01134-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
57 Rahmani N, Hatch J, Dimick M, Naiberg MR, Fiksenbaum L, Andreazza AC, Bowie CR, Dickstein DP, Goldstein BI. Lower pro- to anti-inflammatory ratios associated with reduced neurocognitive flexibility in symptomatic adolescents with bipolar disorder. J Affect Disord 2021;292:430-8. [PMID: 34144368 DOI: 10.1016/j.jad.2021.05.062] [Reference Citation Analysis]
58 Castellani G, Contarini G, Mereu M, Albanesi E, Devroye C, D'Amore C, Ferretti V, De Martin S, Papaleo F. Dopamine-mediated immunomodulation affects choroid plexus function. Brain Behav Immun 2019;81:138-50. [PMID: 31175999 DOI: 10.1016/j.bbi.2019.06.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
59 Zazula R, Dodd S, Dean OM, Berk M, Bortolasci CC, Verri WA Jr, Vargas HO, Nunes SOV. Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder. World J Biol Psychiatry 2021;:1-11. [PMID: 33949291 DOI: 10.1080/15622975.2021.1925152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
60 Hoseth EZ, Ueland T, Dieset I, Birnbaum R, Shin JH, Kleinman JE, Hyde TM, Mørch RH, Hope S, Lekva T, Abraityte AJ, Michelsen AE, Melle I, Westlye LT, Ueland T, Djurovic S, Aukrust P, Weinberger DR, Andreassen OA. A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue. Schizophr Bull 2017;43:881-90. [PMID: 28049760 DOI: 10.1093/schbul/sbw183] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
61 Kogan S, Ospina LH, Kimhy D. Inflammation in individuals with schizophrenia - Implications for neurocognition and daily function. Brain Behav Immun 2018;74:296-9. [PMID: 30218782 DOI: 10.1016/j.bbi.2018.09.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
62 Köhler-Forsberg O, Sylvia L, Deckersbach T, Ostacher MJ, McInnis M, Iosifescu D, Bowden C, McElroy S, Calabrese J, Thase M, Shelton RC, Tohen M, Kocsis J, Friedman E, Ketter T, Nierenberg AA. Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder. Acta Neuropsychiatr 2018;30:297-305. [PMID: 29212563 DOI: 10.1017/neu.2017.34] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
63 Millett CE, Harder J, Locascio JJ, Shanahan M, Santone G, Fichorova RN, Corrigan A, Baecher-Allan C, Burdick KE. TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder. Brain Behav Immun 2020;88:403-10. [PMID: 32272224 DOI: 10.1016/j.bbi.2020.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Kogan S, Ospina LH, Mittal VA, Kimhy D. The impact of inflammation on neurocognition and risk for psychosis: a critical review. Eur Arch Psychiatry Clin Neurosci 2020;270:793-802. [PMID: 31620871 DOI: 10.1007/s00406-019-01073-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
65 Fourrier C, Singhal G, Baune BT. Neuroinflammation and cognition across psychiatric conditions. CNS Spectr 2019;24:4-15. [PMID: 30714555 DOI: 10.1017/S1092852918001499] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
66 Arden R, Luciano M, Deary IJ, Reynolds CA, Pedersen NL, Plassman BL, McGue M, Christensen K, Visscher PM. Authors' Response to Kaufman and Muntaner. Int J Epidemiol 2016;45:578-9. [PMID: 27018017 DOI: 10.1093/ije/dyw020] [Reference Citation Analysis]